Regardless, the strongly increased upregulation of miR-31-5p over the progressive FSHD-like pathogenesis in this chronic DUX4 model suggests that miR-31-5p is a potential FSHD disease biomarker for muscle biopsy. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.